The insider ownership percentage is the key indicator, can be used by investors, to measure the outlook of senior management has on their company. Insider ownership for the OCUL is 3.10%. Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. The Institutional ownership for the OCUL is 53.00%.
Insider trading is the buying or selling of any publicly traded company’s stock and this can be done by someone who has non-public, material information about that OCUL. Insider trading can be illegal or legal depending on when the insider makes the trade. It is illegal when the material information is still non-public. The insider transactions of the company (6-month change in insider ownerships) for the Ocular Therapeutix, Inc. (NASDAQ:OCUL) is 31.53%.
Institutional ownership is the amount of a Ocular Therapeutix, Inc. (NASDAQ:OCUL)’s available stock owned by mutual or pension funds, insurance companies, investment firms, private foundations, endowments or other large entities that actually manage the funds on the behalf of others, so its an interesting element for the traders to note it, and the Institutional ownership for the OCUL is 2.93%.
[FINVIZ TICKER=OCUL]
a Healthcare sector firm, Ocular Therapeutix, Inc. (NASDAQ:OCUL) stock advanced 5.00% on Monday and when day-trade ended the stock finally concluded at $4.62 and number of shares that changed hands during the day are 1.39 Million. The number of shares OCUL stock currently held by all its shareholders are 43.02 and floated shares, the number of shares are available for trading in an open market on last trading day are 37.56. The average volume of shares for 3 months is 784.55 and OCUL stock value has moved between $2.35 – 7.57 in last one year.
The Ocular Therapeutix, Inc. (NASDAQ:OCUL)’s latest earnings date is 8/9/2019. The Gross margin is the difference between the revenue and the cost of goods sold (COGS), divided by revenue. In other words, Gross Margin is a percentage value, while Gross Profit is a monetary value. The valuable gross margin for Ocular Therapeutix, Inc. (NASDAQ:OCUL) is 76.10% and the stock has gained 16.08% in 2019 to date.
U.S. traded shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL)’s monthly stock performance is 59.31%, the quarterly performance is 13.51%, the half year performance is calculated as 11.86%. The yearly performance of OCUL is -36.28%.
The higher the volatility, the riskier the security. For example, when the stock market rises and falls more than one percent over a sustained period of time, it is called a “volatile” market, if the stock price stays relatively stable, the security has low volatility. The Ocular Therapeutix, Inc. (NASDAQ:OCUL) weekly volatility is measured as 6.51% and monthly volatility measured as 10.06%.
Return on assets (ROA) is a main indicator of how profitable a company is relative to its total assets. OCUL return on assets is -80.40%, the return on equity (ROE) of the Ocular Therapeutix, Inc. (NASDAQ:OCUL) is -165.80%, while the most important return on investment is calculates as a percentage and is typically used for personal financial decisions, and OCUL return on investment is -97.40%.
The price to sales ratio is 94.64, and price to book ratio is 7.57.
Analysts mean target price for Ocular Therapeutix, Inc. (NASDAQ:OCUL) is $9.67 while analysts mean recommendation is 2.20. The current share price indicates that stock is -39.30% away from its one year high and is moving 96.60% ahead of its 52-week low. OCUL’s distance from 20 day simple moving average is 18.20% and distance from 50-Day simple moving average is 27.73%.
